FDA Health Law Policy Insurance Medicare/Medicaid Mental Health Off-Label Use Pharmaceuticals Reimbursement Student Fellows Vincent Joralemon Insurance Coverage for Psychedelic Therapy Read more: Insurance Coverage for Psychedelic Therapy
Digital Health FDA Mental Health Off-Label Use Pharmaceuticals Student Fellows Vincent Joralemon Sorry, You Probably Cannot Get MDMA Through Telehealth Read more: Sorry, You Probably Cannot Get MDMA Through Telehealth
Clinical Research FDA Generic Drugs Health Law Policy Intellectual Property Mental Health Pharmaceuticals Student Fellows Vincent Joralemon Ketamine Is the New Viagra Read more: Ketamine Is the New Viagra
FDA Health Law Policy Insurance Mental Health Neuroscience Patient Care Pharmaceuticals Public Health Reimbursement Resource Allocation Student Fellows Vincent Joralemon Psychedelics Are Cheap. Psychedelic Treatment Is Not. Read more: Psychedelics Are Cheap. Psychedelic Treatment Is Not.
A Macro View of Microdosing Health Law Policy Mental Health Neuroscience Scientific Evidence What Macrodosing Can Learn from Microdosing Read more: What Macrodosing Can Learn from Microdosing
A Macro View of Microdosing Health Law Policy Mental Health Neuroscience Scientific Evidence A Precise Definition of Microdosing Psychedelics is Needed to Promote Equitable Regulation Read more: A Precise Definition of Microdosing Psychedelics is Needed to Promote Equitable Regulation
Addiction Announcements Chloe Reichel FDA Featured Health Law Policy Informed Consent Insurance Intellectual Property Mason Marks Mental Health Neuroscience Off-Label Use Opioid Crisis Petrie-Flom Center Pharmaceuticals Public Health Race Research Funding Scientific Evidence Q&A with Mason Marks on New Psychedelics Law and Regulation Initiative Read more: Q&A with Mason Marks on New Psychedelics Law and Regulation Initiative